Overview
Pfizer Limited, a subsidiary of the global pharmaceutical giant Pfizer Inc., is a prominent player in the Indian healthcare industry. Established in 1950, Pfizer Limited operates across various therapeutic areas, offering a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products. The Company has a portfolio of over 150 products across 15 therapeutic areas. Its top brands include Prevenar 13, Corex – DX, Dolonex, Enbrel, Becosules and Folvite among others. In addition to its commercial operations, Pfizer Limited also operates a state-of-the-art, award-winning manufacturing facility in Goa.
AI+ Ask Fintel’s AI assistant about Pfizer Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Pfizer Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 5,685.00 MM |
| Earnings Date | |
| EPS (TTM) | 1.89 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-07-25 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.05 |
| ROE | 0.12 |
| ROIC | 0.07 |
| CROIC | 0.00 |
| OCROIC | 0.10 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 20.09 /100 |
| Profitability | 62.48 /100 |
| Quality Score | 50.76 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | 23.70 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 8.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Pfizer Inc. is $32.99. The forecasts range from a low of $23.30 to a high of $52.67. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Pfizer Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-10 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-05-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-05-02 | BMO Capital | Outperform | Outperform | Reiterate |
| 2024-04-18 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-03-22 | Argus Research | Buy | Hold | Downgrade |
| 2024-03-04 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-03-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-23 | Guggenheim | Buy | Initiate | |
| 2024-01-31 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-04 | TD Cowen | Outperform | Market Perform | Downgrade |
| 2023-12-14 | UBS | Neutral | Neutral | Maintains |
| 2023-12-14 | Truist Securities | Buy | Buy | Maintains |
| 2023-12-14 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-12-04 | Truist Securities | Buy | Buy | Reiterate |
| 2023-11-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-01 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-17 | Truist Securities | Buy | Buy | Maintains |
| 2023-10-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-17 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-16 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-10-16 | Citigroup | Neutral | Neutral | Maintains |
| 2023-10-16 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-10-16 | Jefferies | Hold | Buy | Upgrade |
| 2023-10-16 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-06 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-10-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-09-18 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-09-13 | Truist Securities | Buy | Buy | Reiterate |
| 2023-09-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-30 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-02 | Truist Securities | Buy | Buy | Maintains |
| 2023-08-02 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-07-21 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-14 | HSBC | Buy | Initiate | |
| 2023-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-07-11 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-06-29 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2023-06-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-06-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-05-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-05-11 | Daiwa Capital | Outperform | Neutral | Downgrade |
| 2023-05-03 | Credit Suisse | Outperform | Maintains | |
| 2023-05-03 | Barclays | Equal-Weight | Maintains | |
| 2023-04-21 | B of A Securities | Neutral | Maintains | |
| 2023-04-12 | Barclays | Equal-Weight | Maintains | |
| 2023-04-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-03-17 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-03-06 | Jefferies | Hold | Initiate | |
| 2023-02-07 | Daiwa Capital | Neutral | Outperform | Upgrade |
| 2023-02-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-01 | BMO Capital | Outperform | Maintains | |
| 2023-02-01 | Credit Suisse | Outperform | Maintains | |
| 2023-02-01 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2023-02-01 | Barclays | Equal-Weight | Maintains | |
| 2023-02-01 | Atlantic Equities | Neutral | Maintains | |
| 2023-02-01 | SVB Leerink | Market Perform | Maintains | |
| 2023-01-26 | UBS | Buy | Neutral | Downgrade |
| 2023-01-17 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2023-01-04 | B of A Securities | Buy | Neutral | Downgrade |
| 2022-12-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-12-13 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2022-11-18 | Credit Suisse | Outperform | Initiate | |
| 2022-11-03 | SVB Leerink | Market Perform | Maintains | |
| 2022-11-02 | Wells Fargo | Overweight | Maintains | |
| 2022-11-02 | Barclays | Equal-Weight | Maintains | |
| 2022-11-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-12 | Barclays | Equal-Weight | Maintains | |
| 2022-10-11 | SVB Leerink | Market Perform | Maintains | |
| 2022-08-01 | Barclays | Equal-Weight | Maintains | |
| 2022-07-29 | SVB Leerink | Market Perform | Maintains | |
| 2022-07-08 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-04 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-04 | Wells Fargo | Overweight | Maintains | |
| 2022-04-05 | Citigroup | Neutral | Maintains | |
| 2022-02-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-07 | Wells Fargo | Overweight | Maintains | |
| 2022-01-05 | B of A Securities | Neutral | Buy | Upgrade |
| 2021-12-17 | Goldman Sachs | Neutral | Initiate | |
| 2021-12-15 | SVB Leerink | Market Perform | Maintains | |
| 2021-12-14 | Mizuho | Neutral | Maintains | |
| 2021-12-13 | UBS | Neutral | Buy | Upgrade |
| 2021-12-10 | Barclays | Equal-Weight | Maintains | |
| 2021-12-09 | Wells Fargo | Overweight | Initiate | |
| 2021-11-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-11-19 | BMO Capital | Outperform | Initiate | |
| 2021-11-03 | SVB Leerink | Market Perform | Maintains | |
| 2021-10-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-09-20 | SVB Leerink | Market Perform | Maintains | |
| 2021-07-30 | Mizuho | Neutral | Maintains | |
| 2021-07-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-07-29 | SVB Leerink | Market Perform | Maintains | |
| 2021-06-17 | RBC Capital | Sector Perform | Maintains | |
| 2021-05-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-05-06 | Mizuho | Buy | Neutral | Downgrade |
| 2021-05-05 | SVB Leerink | Market Perform | Maintains | |
| 2021-03-26 | SVB Leerink | Market Perform | Maintains | |
| 2021-02-04 | DZ Bank | Hold | Buy | Upgrade |
| 2021-02-03 | Mizuho | Buy | Maintains | |
| 2021-02-03 | SVB Leerink | Market Perform | Maintains | |
| 2021-01-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-12-16 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2020-11-19 | Goldman Sachs | Neutral | Reiterate | |
| 2020-11-10 | Bernstein | Market Perform | Initiate | |
| 2020-10-28 | SVB Leerink | Market Perform | Maintains | |
| 2020-10-23 | Truist Securities | Buy | Initiate | |
| 2020-10-12 | Atlantic Equities | Overweight | Neutral | Downgrade |
| 2020-09-29 | Berenberg | Hold | Initiate | |
| 2020-07-30 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-07-29 | UBS | Neutral | Maintains | |
| 2020-07-29 | SVB Leerink | Market Perform | Maintains | |
| 2020-06-16 | SVB Leerink | Market Perform | Initiate | |
| 2020-06-01 | JP Morgan | Neutral | Maintains | |
| 2020-04-29 | Barclays | Equal-Weight | Maintains | |
| 2020-04-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-03-27 | RBC Capital | Outperform | Maintains | |
| 2020-02-27 | Barclays | Equal-Weight | Initiate | |
| 2020-02-06 | Mizuho | Buy | Initiate | |
| 2020-01-07 | RBC Capital | Outperform | Initiate | |
| 2019-08-28 | DZ Bank | Sell | Hold | Upgrade |
| 2019-08-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-07-30 | Bank of America | Buy | Neutral | Downgrade |
| 2019-07-30 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2019-04-01 | Bank of America | Buy | Buy | Maintains |
| 2019-01-31 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2019-01-31 | Argus | Neutral | Outperform | Upgrade |
| 2019-01-23 | UBS | Buy | Neutral | Downgrade |
| 2018-12-11 | JP Morgan | Overweight | Neutral | Downgrade |
| 2018-11-06 | Citigroup | Sell | Sell | Maintains |
| 2018-11-01 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2018-10-31 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-08-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-08-23 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-08-01 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-08-01 | Bank of America | Buy | Buy | Maintains |
| 2018-08-01 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-05-02 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-04-05 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2018-01-31 | Barclays | Overweight | Overweight | Maintains |
| 2018-01-31 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-31 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-01-31 | Leerink Swann | Market Perform | Market Perform | Maintains |
| 2017-10-19 | BMO Capital | Outperform | Maintains | |
| 2017-09-20 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2017-08-02 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2017-07-20 | Credit Suisse | Neutral | Maintains | |
| 2017-05-16 | Citigroup | Neutral | Sell | Downgrade |
| 2016-12-02 | Guggenheim | Neutral | Initiate | |
| 2016-11-29 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2016-11-02 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2016-11-02 | Argus | Buy | Hold | Downgrade |
| 2016-10-13 | Jefferies | Buy | Hold | Downgrade |
| 2016-09-13 | Jefferies | Buy | Maintains | |
| 2016-08-04 | Jefferies | Buy | Maintains | |
| 2016-07-14 | Jefferies | Buy | Maintains | |
| 2016-06-20 | Jefferies | Buy | Maintains | |
| 2016-06-14 | Jefferies | Buy | Maintains | |
| 2016-05-12 | Berenberg | Hold | Initiate | |
| 2016-05-09 | Credit Suisse | Outperform | Maintains | |
| 2016-05-05 | Leerink Swann | Market Perform | Maintains | |
| 2016-05-02 | Leerink Swann | Market Perform | Maintains | |
| 2016-04-07 | Jefferies | Buy | Maintains | |
| 2016-04-06 | Societe Generale | Hold | Initiate | |
| 2016-02-16 | SunTrust Robinson Humphrey | Neutral | Maintains | |
| 2016-02-11 | Argus | Buy | Maintains | |
| 2016-01-14 | Jefferies | Buy | Maintains | |
| 2015-12-18 | Atlantic Equities | Overweight | Initiate | |
| 2015-11-25 | SunTrust Robinson Humphrey | Reduce | Neutral | Upgrade |
| 2015-11-03 | Argus | Buy | Maintains | |
| 2015-10-20 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2015-10-02 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-08-07 | Jefferies | Buy | Maintains | |
| 2015-06-17 | PiperJaffray | Overweight | Initiate | |
| 2015-06-17 | Jefferies | Overweight | Initiate | |
| 2015-04-29 | JP Morgan | Overweight | Maintains | |
| 2015-04-29 | Deutsche Bank | Buy | Maintains | |
| 2015-03-23 | Jefferies | Buy | Maintains | |
| 2015-03-11 | Deutsche Bank | Buy | Maintains | |
| 2015-02-20 | Jefferies | Buy | Maintains | |
| 2015-02-10 | JP Morgan | Overweight | Maintains | |
| 2015-02-09 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2015-02-09 | Citigroup | Buy | Maintains | |
| 2014-12-18 | Deutsche Bank | Buy | Maintains | |
| 2014-10-13 | Jefferies | Buy | Maintains | |
| 2014-08-27 | Deutsche Bank | Buy | Initiate | |
| 2014-07-28 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2014-07-14 | Jefferies | Buy | Maintains | |
| 2014-07-02 | Barclays | Equal-Weight | Maintains | |
| 2014-05-08 | Credit Suisse | Outperform | Maintains | |
| 2014-05-02 | Credit Suisse | Outperform | Maintains | |
| 2014-04-29 | Citigroup | Buy | Maintains | |
| 2014-04-14 | Jefferies | Buy | Maintains | |
| 2014-03-14 | Morgan Stanley | Overweight | Maintains | |
| 2014-03-13 | SunTrust Robinson Humphrey | Reduce | Maintains | |
| 2014-02-21 | Bank of America | Buy | Maintains | |
| 2014-02-04 | Jefferies | Hold | Buy | Upgrade |
| 2014-01-27 | Atlantic Equities | Overweight | Maintains | |
| 2014-01-10 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2013-12-19 | Morgan Stanley | Overweight | Maintains | |
| 2013-11-14 | LBBW Research | Hold | Buy | Upgrade |
| 2013-10-08 | Credit Suisse | Outperform | Initiate | |
| 2013-07-12 | Jefferies | Buy | Hold | Downgrade |
| 2013-07-02 | Standpoint Research | Hold | Sell | Downgrade |
| 2013-06-07 | Jefferies | Buy | Maintains | |
| 2013-04-17 | BMO Capital | Outperform | Maintains | |
| 2013-04-10 | Jefferies | Buy | Maintains | |
| 2013-03-07 | Morgan Stanley | Overweight | Maintains | |
| 2013-03-04 | Bank of America | Buy | Maintains | |
| 2013-01-30 | Goldman Sachs | Buy | Maintains | |
| 2013-01-30 | BMO Capital | Outperform | Maintains | |
| 2013-01-30 | UBS | Buy | Maintains | |
| 2013-01-30 | JP Morgan | Overweight | Maintains | |
| 2013-01-29 | Hilliard Lyons | Long-Term Buy | Maintains | |
| 2013-01-28 | BMO Capital | Outperform | Maintains | |
| 2013-01-16 | Jefferies | Buy | Maintains | |
| 2012-12-13 | JP Morgan | Overweight | Maintains | |
| 2012-11-30 | Citigroup | Buy | Initiate | |
| 2012-11-29 | Citigroup | Buy | Maintains | |
| 2012-11-27 | MKM Partners | Buy | Neutral | Downgrade |
| 2012-11-12 | Jefferies | Buy | Maintains | |
| 2012-11-02 | BMO Capital | Outperform | Maintains | |
| 2012-10-15 | Barclays | Equal-Weight | Maintains | |
| 2012-10-12 | Jefferies | Buy | Maintains | |
| 2012-10-04 | Morgan Stanley | Overweight | Maintains | |
| 2012-08-09 | Jefferies | Buy | Maintains | |
| 2012-07-31 | Bank of America | Buy | Maintains | |
| 2012-07-18 | Morgan Stanley | Overweight | Maintains | |
| 2012-07-13 | Jefferies | Buy | Maintains | |
| 2012-04-09 | ISI Group | Buy | Initiate | |
| 2012-04-02 | Citigroup | Neutral | Maintains | |
| 2012-03-27 | Goldman Sachs | Buy | Maintains | |
| 2024-12-11 | Guggenheim | Buy | Buy | Maintains |
| 2024-09-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-03-12 | Guggenheim | Buy | Buy | Reiterate |
| 2025-01-08 | UBS | Neutral | Neutral | Maintains |
| 2024-07-31 | UBS | Neutral | Neutral | Maintains |
| 2024-07-31 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-31 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-31 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-17 | Bernstein | Market Perform | Initiate | |
| 2024-11-15 | Wolfe Research | Underperform | Initiate | |
| 2024-08-08 | Daiwa Capital | Neutral | Outperform | Upgrade |
| 2025-01-28 | Citigroup | Neutral | Neutral | Maintains |
| 2024-10-25 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-03 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-09-16 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-12-18 | Truist Securities | Buy | Buy | Maintains |
| 2025-02-10 | Guggenheim | Buy | Buy | Reiterate |
| 2024-08-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-12-10 | B of A Securities | Neutral | Reiterate | |
| 2025-03-18 | Guggenheim | Buy | Buy | Reiterate |
| 2025-04-08 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2025-04-08 | UBS | Neutral | Neutral | Maintains |
| 2025-04-30 | UBS | Neutral | Neutral | Maintains |
| 2025-04-22 | Cantor Fitzgerald | Neutral | Initiate | |
| 2025-08-06 | Citigroup | Neutral | Neutral | Maintains |
| 2025-08-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-06 | B of A Securities | Neutral | Neutral | Maintains |
